|
1
|
Ostrom QT, Price M, Neff C, Cioffi G,
Waite KA, Kruchko C and Barnholtz-Sloan JS: CBTRUS statistical
report: Primary brain and other central nervous system tumors
diagnosed in the United States in 2015–2019. Neuro Oncol. 24 (Suppl
5):v1–v95. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wen PY, Weller M, Lee EQ, Alexander BM,
Barnholtz-Sloan JS, Barthel FP, Batchelor TT, Bindra RS, Chang SM,
Chiocca EA, et al: Glioblastoma in adults: A society for
neuro-oncology (SNO) and european society of neuro-oncology (EANO)
consensus review on current management and future directions. Neuro
Oncol. 22:1073–1113. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: Radiotherapy plus concomitant and adjuvant temozolomide
for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Delgado-López PD and Corrales-García EM:
Survival in glioblastoma: A review on the impact of treatment
modalities. Clin Transl Oncol. 18:1062–1071. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Krex D, Klink B, Hartmann C, von Deimling
A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger
G, et al: Long-term survival with glioblastoma multiforme. Brain.
130:2596–2606. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Scott JN, Rewcastle NB, Brasher PM, Fulton
D, MacKinnon JA, Hamilton M, Cairncross JG and Forsyth P: Which
glioblastoma multiforme patient will become a long-term survivor? A
population-based study. Ann Neurol. 46:183–188. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Carew JS and Huang P: Mitochondrial
defects in cancer. Mol Cancer. 1:92002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Seyfried TN and Mukherjee P: Targeting
energy metabolism in brain cancer: Review and hypothesis. Nutr
Metab. 2:302005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chinopoulos C and Seyfried TN:
Mitochondrial substrate-level phosphorylation as energy source for
glioblastoma: Review and hypothesis. ASN Neuro.
10:17590914188182612018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
de Cabo R and Mattson MP: Effects of
intermittent fasting on health, aging, and disease. N Engl J Med.
381:2541–2551. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nencioni A, Caffa I, Cortellino S and
Longo VD: Fasting and cancer: Molecular mechanisms and clinical
application. Nat Rev Cancer. 18:707–719. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Seyfried TN, Arismendi-Morillo G,
Mukherjee P and Chinopoulos C: On the origin of ATP synthesis in
cancer. iScience. 23:1017612020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Oudard S, Boitier E, Miccoli L, Rousset S,
Dutrillaux B and Poupon MF: Gliomas are driven by glycolysis:
Putative roles of hexokinase, oxidative phosphorylation and
mitochondrial ultrastructure. Anticancer Res. 17:1903–1911.
1997.PubMed/NCBI
|
|
16
|
Arismendi-Morillo GJ and
Castellano-Ramirez AV: Ultrastructural mitochondrial pathology in
human astrocytic tumors: Potentials implications pro-therapeutics
strategies. J Electron Microsc. 57:33–39. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liang BC: Evidence for association of
mitochondrial DNA sequence amplification and nuclear localization
in human low-grade gliomas. Mutat Res. 354:27–33. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liang BC and Hays L: Mitochondrial DNA
copy number changes in human gliomas. Cancer Lett. 105:167–173.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Feichtinger RG, Weis S, Mayr JA,
Zimmermann F, Geilberger R, Sperl W and Kofler B: Alterations of
oxidative phosphorylation complexes in astrocytomas. Glia.
62:514–525. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Deighton RF, Le Bihan T, Martin SF, Gerth
AMJ, McCulloch M, Edgar JM, Kerr LE, Whittle IR and McCulloch J:
Interactions among mitochondrial proteins altered in glioblastoma.
J Neurooncol. 118:247–256. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Winter SF, Loebel F and Dietrich J: Role
of ketogenic metabolic therapy in malignant glioma: A systematic
review. Crit Rev Oncol Hematol. 112:41–58. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Meidenbauer JJ, Mukherjee P and Seyfried
TN: The glucose ketone index calculator: A simple tool to monitor
therapeutic efficacy for metabolic management of brain cancer. Nutr
Metab. 12:122015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
de Groot S, Pijl H, van der Hoeven JJM and
Kroep JR: Effects of short-term fasting on cancer treatment. J Exp
Clin Cancer Res. 38:2092019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miller VJ, Villamena FA and Volek JS:
Nutritional ketosis and mitohormesis: Potential implications for
mitochondrial function and human health. J Nutr Metab.
2018:51576452018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dal Bello S, Valdemarin F, Martinuzzi D,
Filippi F, Gigli GL and Valente M: Ketogenic diet in the treatment
of gliomas and glioblastomas. Nutrients. 14:38512022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Phillips MCL, Leyden J, McManus EJ, Lowyim
DG, Ziad F, Moon BG, Haji Mohd Yasin NAB, Tan A, Thotathil Z and
Jameson MB: Feasibility and safety of a combined metabolic strategy
in glioblastoma multiforme: A prospective case series. J Oncol.
2022:44967342022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu W, Klockow JL, Zhang M, Lafortune F,
Chang E, Jin L, Wu Y and Daldrup-Link HE: Glioblastoma multiforme
(GBM): An overview of current t9erapies and mechanisms of
resistance. Pharmacol Res. 171:1057802021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Raffaghello L, Lee C, Safdie FM, Wei M,
Madia F, Bianchi G and Longo VD: Starvation-dependent differential
stress resistance protects normal but not cancer cells against
high-dose chemotherapy. Proc Natl Acad Sci USA. 105:8215–8220.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Seyfried TN, Yu G, Maroon JC and
D'Agostino DP: Press-pulse: A novel therapeutic strategy for the
metabolic management of cancer. Nutr Metab. 14:192017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zuccoli G, Marcello N, Pisanello A,
Servadei F, Vaccaro S, Mukherjee P and Seyfried TN: Metabolic
management of glioblastoma multiforme using standard therapy
together with a restricted ketogenic diet: Case report. Nutr Metab.
7:332010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Elsakka AMA, Bary MA, Abdelzaher E,
Elnaggar M, Kalamian M, Mukherjee P and Seyfried TN: Management of
glioblastoma multiforme in a patient treated with ketogenic
metabolic therapy and modified standard of care: A 24-month
follow-up. Front Nutr. 5:202018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Seyfried TN, Shivane AG, Kalamian M,
Maroon JC, Mukherjee P and Zuccoli G: Ketogenic metabolic therapy,
without chemo or radiation, for the long-term management of
IDH1-mutant glioblastoma: An 80-month follow-up case report. Front
Nutr. 8:6822432021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pitter KL, Tamagno I, Alikhanyan K,
Hosni-Ahmed A, Pattwell SS, Donnola S, Dai C, Ozawa T, Chang M,
Chan TA, et al: Corticosteroids compromise survival in
glioblastoma. Brain. 139:1458–1471. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Klement RJ and Champ CE: Corticosteroids
compromise survival in glioblastoma in part through their elevation
of blood glucose levels. Brain. 140:e162017.PubMed/NCBI
|
|
36
|
Luo J, Hendryx M, Manson JE, Figueiredo
JC, LeBlanc ES, Barrington W, Rohan TE, Howard BV, Reding K, Ho GY,
et al: Intentional weight loss and obesity-related cancer risk.
JNCI Cancer Spectr. 3:kz0542019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
MacKintosh ML, Derbyshire AE, McVey RJ,
Bolton J, Nickkho-Amiry M, Higgins CL, Kamieniorz M, Pemberton PW,
Kirmani BH, Ahmed B, et al: The impact of obesity and bariatric
surgery on circulating and tissue biomarkers of endometrial cancer
risk. Int J Cancer. 144:641–650. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Phillips MCL: Fasting as a therapy in
neurological disease. Nutrients. 11:25012019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Weber DD, Aminzadeh-Gohari S, Tulipan J,
Catalano L, Feichtinger RG and Kofler B: Ketogenic diet in the
treatment of cancer-where do we stand? Mol Metab. 33:102–121. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Goldhamer AC, Klaper M, Foorohar A and
Myers TR: Water-only fasting and an exclusively plant foods diet in
the management of stage IIIa, low-grade follicular lymphoma. BMJ
Case Rep. 2015:bcr20152115822015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Phillips MCL, Murtagh DKJ, Sinha SK and
Moon BG: Managing metastatic thymoma with metabolic and medical
therapy: A case report. Front Oncol. 10:5782020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cruzat V, Macedo Rogero M, Noel Keane K,
Curi R and Newsholme P: Glutamine: Metabolism and immune function,
supplementation and clinical translation. Nutrients. 10:15642018.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mukherjee P, Augur ZM, Li M, Hill C,
Greenwood B, Domin MA, Kondakci G, Narain NR, Kiebish MA, Bronson
RT, et al: Therapeutic benefit of combining calorie-restricted
ketogenic diet and glutamine targeting in late-stage experimental
glioblastoma. Commun Biol. 2:2002019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Takhwifa F, Aninditha T, Setiawan H and
Sauriasari R: The potential of metformin as an antineoplastic in
brain tumors: A systematic review. Heliyon. 7:e065582021.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jiang W, Hu J and He X, Jin W and He X:
Statins: A repurposed drug to fight cancer. J Exp Clin Cancer Res.
40:2412021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Baul PB, Deepak AD, Kakkar M and Modi S:
Effect of atorvastatin on blood ketone levels and glycemic control
in patients with type 2 diabetes mellitus: A single arm pilot
study. Diabetes Metab Syndr. 14:1333–1337. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Smith KA, Hendricks BK, DiDomenico JD,
Conway BN, Smith TL, Azadi A and Fonkem E: Ketogenic metabolic
therapy for glioma. Cureus. 14:e264572022.PubMed/NCBI
|
|
48
|
Brown NF, Ottaviani D, Tazare J, Gregson
J, Kitchen N, Brandner S, Fersht N and Mulholland P: Survival
outcomes and prognostic factors in glioblastoma. Cancers.
14:31612022. View Article : Google Scholar : PubMed/NCBI
|
